CD46 and prostate carcinoma: Another highly expressed mCRP by prostate cancer cells is CD46, a transmembrane glycoprotein expressed on all nucleated cells, that functions to protect excessive complement activation by acting as a cofactor in the proteolytic cleavage of C3b and C4b, mediated by Factor I.